SlideShare a Scribd company logo
1 of 11
GPAT-MCQS-SERIES
PART-2
AUTONOMIC NERVOUS SYSTEM
Jsmasipharmacy.blogspot.com
SYLLABUS: Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics,
Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers.
Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic
agents. Drugs used in Myasthenia Gravis.
1. Cholinergic M2 - and M3- receptors produce following effects:
[P] Decreased heart rate
[Q] Dilatation effect on salivary gland
[R] Increased heart rate
[S] Effect on erectile tissue
(a) P and Q (b) Q and R (c) Q and S (d) P and S
2. Following statements are true:
[P] Substance P is located at sympathetic ganglia
[Q] Neuropeptide Y is located at postganglionic sympathetic neurons
[R] Nitric oxide located at enteric neurons
[S] Gonadotrophin-releasing hormone is not located at sympathetic ganglia
(a) P and Q (b) P and R (c) Q and R (d) R and S
3. Following statements are true:
[P] GABA transmitter is responsible for peristaltic reflex
[Q] Neuropeptide Y facilitates constrictor action of adrenaline and inhibits adrenaline release
[R] Substance P is co-transmitter with acetylcholine
[S] Dopamine transmitter is responsible for vasoconstrictor
(a) P and Q (b) Q and R (c) P and R (d) R and S
4. Following are the agonist of nicotinic receptor (α3)2:
[P] Carbachol [Q] Trimetaphan
[R] Hexamethonium [S] Acetylcholine
(a) P and S (b) Q and R (c) P and R (d) R and S
5. Following are the agonist of muscarinic receptor M2:
[P] Dicycloverine [Q] Ipratropium
[R] Carbachol [S] Talsaclidine
(a) Q and S (b) Q and R (c) P and Q (d) R and S
6. Following are the antagonist of nicotinic receptor (α1)2:
[P] Cytosine [Q] Epibatidine
[R] Atracurium [S] Vecuronium
(a) Q and S (b) Q and R (c) P and Q (d) R and S
7. Following are the antagonist of muscarinic receptor:
[P] Oxotremorine [Q] Oxybutynin
[R] Tolterodine [S] Carbachol
(a) Q and S (b) Q and R (c) P and Q (d) R and S
8. M2 receptor is responsible for following effects:
[P] Cardiac inhibition [Q] Neural inhibition
[R] Gastric secretion [S] Vasodilatation
(a) P and Q (b) P and R (c) Q and S (d) Q and R
9. Following drugs lower the interocular pressure
[P] Pilocarpine [Q] Lananoprost
[R] Atropine [S] Tiotropium
(a) P and Q (b) P and R (c) Q and S (d) Q and R
10. In urinary incontinence following drug is widely used:
(a) Pirenzepine (b) Cyclopentolate
(c) Darifenacin (d) Hyoscine
11. The main side effect of tubocurarine is
[P] Bradycardia [Q] Bronchoconstriction
[R] Hypotension [S] Cardiac arrhythmia
(a) R and S (b) P and R (c) Q and S (d) Q and R
12. Following statements are true:
[P] Hemicholinium inhibits the acetylcholine synthesis
[Q] Parathion is a short duration anticholineterase
[R] Botulinum toxin inhibits acetylcholine release
[S] Physostigmine is used in treatment of myasthenia gravis
(a) Q and R (b) P and R (c) R and S (d) P and Q
13. In the treatment of myasthenia gravis, the best agent for distinguishing between myashenic
crisis and cholinergic crisis, given intravenously, is
(a) Pyridostigmine (b) Edrophonium (c) Physostigmine (d) Neostigmine
14. Which of the following drug may cause cycloplegia when used topically in the eye?
(a) Bethanechol (b) Physostigmine (c) Atropine (d) Pilocarpine
15. Epinephrine is added to local anaesthetics
(a) To cause haemeostasis
(b) To prolong the action of local anaesthetics
(c) To stimulate wound healing
(d) All of the above
16. Neostigmine may cause all of the followings except
(a) Block accommodation reflex
(b) Reversible inhibition of acetyl cholinesterase
(c) Constipation
(d) Bronchoconstriction
17. Following statements are true for β2 receptor
[P] It produces glycogenolysis effect
[Q] It produces lipolysis effect
[R] It relaxes uterus
[S] It produces constriction effect on bronchi
(a) Q and S (b) Q and R (c) P and R (d) P and Q
18. Following statements are true for ritodrine
[P] It is β2 agonist
[Q] It produces arrhythmia as side effect
[R] It is β1 agonist
[S] It is used for nasal decongestion
(a) P and Q (b) Q and R (c) P and R (d) Q and S
19. Following statement is true for labetalol
[P] It is α and β antagonist
[Q] It produces tachycardia as side effect
[R] It is non-selective β antagonist
[S] It is used in hypertension in pregnancy
(a) Q and R (b) P and Q (c) P and S (d) R and S
20. Atropine over dosage may causes all of the following except
(a) Miosis
(b) Increased heart rate
(c) Relaxation of GIT smooth muscle
(d) Mental aberration
21. Orally effective sympathomimetics agent is
[P] Epinephrine [Q] Isoproterenol
[R] Ephedrine [S] Amphetamine
(a) P and Q (b) Q and R (c) Q and S (d) R and S
22. Pilocarpineis classified as
(a) Cholinesterase inhibitor
(b) Sympathomimetic
(c) Cholinomimetic
(d) Cholinolytics
23. Propranolol is contraindicated in patients with
(a) Angina pectoris
(b) Supraventricular arrhythmias
(c) Glaucoma
(d) Hypertension
24. Mechanism of action of organic phosphate parathion is
(a) Phosphorylation of the cationic site of cholinesterases
(b) Phosphorylation of the esteratic site of cholinesterases
(c) Acetylation of the esteratic site of cholinesterases
(d) Acetylation of the cationic site of cholinesterases
25. Muscarinic receptor M3 are mainly located at
[P] Exocrine gland [Q] Cerebral cortex
[R] Heart [S] CNS
(a) P and S (b) Q and R (c) P and R (d) R and S
26. Neostigmine effectively antagonizes skeletal muscle relaxation produced by
(a) Tubocurarine (b) Gallamine (c) Pancuronium (d) All of the above
27. All of the following statements related to neostigmine are correct except
(a) Neostigmine is a quaternary ammonium compound
(b) Neostigmine is medium duration of action
(c) Neostigmine has direct effect on neuromuscular junctions
(d) All of the above
28. Muscarinic receptor M4 are mainly located at
(a) Exocrine gland (b) Cerebral cortex (c) Heart (d) CNS
29. Antidote of atropine is
(a) Neostigmine (b) Pralidoxime (c) Physostigmine (d) None of above
30. Atropine blocks the muscarinic actions of acetylcholine by
(a) Inhibiting synthesis of ACH
(b) Inhibiting release from storage sites
(c) Competing at receptor sites
(d) All of the above
31. Sweating is inhibited by
(a) Atropine (b) Phenothiazines (c) Scopolamines (d) All of the above
32. Beta agonist used in bronchial asthma exert action by
(a) Blocking B1 receptor
(b) Blocking B2 receptor
(c) Stimulating B1 receptor
(d) Stimulating B2 receptor
33. Which of the following agent irreversibly bound with acetyl cholinesterase
(a) Dispropyl flurophosphate
(b) Ecothiopate
(c) Both a and b
(d) None of the above
34. Alcuronium is a semisynthetic derivative with similar properties of
(a) Gallamine (b) Pancuronium (c) Succinylcholine (d) D-tubocurarine
35. Which of the following a is directly acting sympathomimetic agent?
(a) Ephedrine (b) Amphetamine (c) Dopamine (d) All of the above
36. Antidote of organo phosphorous poisoning is
(a) Physostigmine (b) Pralidoxime (c) Neostigmine (d) Tubocurarine
37. Action of D-tubocurarine is
(a) Competitive blockade of musscarinic receptors
(b) Competitive blockade of nicotinic receptors
(c) Irreversible blockade of muscarinic receptor
(d) None of above
38. Gingival hyperplasia is an oral condition possible in using
(a) Phenobarbital (b) Phenytoin (c) Pentobarbital (d) Valproic acid
39. Which of the following agent is a cholinesterase re-activator?
(a) Pilocarpine (b) Pralidoxime (c) Neostigmine (d) Physostigmine
40. Which of the following drug inhibits the acetylcholine synthesis?
(a) Neomycin (b) Vasamicol (c) Botulinum toxin (d) Atropine
41. Tachyphylaxis is an unwanted effect of
(a) Methohexamine (b) Methylphenidate (c) Ephedrine (d) Methamphetamine
42. Activation of alpha-2 receptors in the pancreatic islets causes
(a) Suppression of insulin secretion
(b) Stimulation of insulin release
(c) Suppression of glucagon secretion
(d) None of above
43. Darifenacin is a
(a) M1 antagonist (b) M2 antagonist(c) M3 agonist (d) M3 antagonist
44. Which of the following drugs. do(es) not cross the blood–brain barrier?
(a) Physostigmine (b) Neostigmine (c) Atropine (d) All of the above
45. Drug of choice in the treatment of cardiogenic shock is/are
(a) Isoproterenol (b) Epinephrine (c) Dopamine (d) All of the above
46. Which of the following muscle relaxant has peripheral action?
(a) Diazepam (b) Mephenesin (c) D-Tubocurarine (d) Orphenadrine
47. Pilocarpine is best used in
(a) Congential glaucoma
(b) Open angle glaucoma
(c) Secondary glaucoma
(d) All of the above
48. Timolol reduces the intraocular pressure by which mechanism of action?
(a) Muscarinic agonist
(b) Anticholinestarase
(c) Carbonic anhydrase inhibitor
(d) Beta-adrenoceptor antagonist
49. For glycogenolysis in liver one of the following adrenoreceptor is responsible:
(a) Alpha-1 receptor
(b) Alpha-2 receptor
(c) Beta-1 receptor
(d) Beta-2 receptor
50. Cardiac effects of epinephrine includes all except
(a) Act on B – receptor of myocardium
(b) Induced cardiac arrhythmias are blocked by propranolol
(c) Prolong refractory period of AV nodes
(d) Decrease the Amplitude of the T-waves of ECG
51. Serious unwanted effect of epinephrine is
(a) Respiratory difficulty (b) Palpitation (c) Cerebral heamorrhage (d) Tremor
52. Drug of choice in motion sickness is
(a) Atropine (b) Scopolamine (c) Carbamazepine (d) Metoclopromide
53. In belladonna poisoning convulsions can be controlled by
(a) Paraldehyde (b) Phenytoin (c) Diazepam (d) Carbamazepine
54. Atropine are is used prior the administration of a general Aanaesthetics agent due tobecause
it
(a) Inhibits salivation and secretions of respiratory tract
(b) Inhibits GIT motility
(c) Prevents miosis
(d) Causes skeletal muscle relaxation
55. Major adverse effect of clonidine is
(a) Bradycardia (b) Tachycardia (c) Sexual dysfunction (d) Dry mouth
56. Ganglionic blocking agents may cause all of the following except
(a) Mydriasis
(b) Loss of accommodation
(c) Reduced sweating is reduce
(d) Inhibit erection and ejaculation
Answer Keys
1. (a) 2. (a) 3. (c) 4. (c) 5. (d) 6. (d) 7. (a) 8. (a) 9. (a) 10. (c) 11. (d) 12. (b) 13. (b) 14. (c) 15. (b)
16. (c) 17. (c) 18. (a) 19. (c) 20. (a) 21. (d) 22. (c) 23. (c) 24. (b) 25. (a) 26. (d) 27. (d) 28. (d) 29.
(c) 30. (d) 31. (d) 32. (d) 33. (c) 34. (d) 35. (c) 36. (b) 37. (b) 38. (b) 39. (b) 40. (b) 41. (c) 42. (a)
43. (d) 44. (b) 45. (c) 46. (c) 47. (b) 48. (d) 49. (a) 50. (c) 51. (c) 52. (b) 53. (c) 54. (a) 55. (d) 56.
(d)

More Related Content

What's hot

Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundPuja Ramu Basule
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptxGitanjaliMehetre1
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug DesignSagar Magar
 
Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents Soujanya Pharm.D
 
Code of Pharmaceutical Ethics
Code of Pharmaceutical EthicsCode of Pharmaceutical Ethics
Code of Pharmaceutical EthicsGanesh Shevalkar
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsDHARMENDRA BARIA
 
Medicinal chemistry of local anaesthetics
Medicinal chemistry of local anaestheticsMedicinal chemistry of local anaesthetics
Medicinal chemistry of local anaestheticssuresh bairi
 
Practical MCQ Bank for experiments: Medicinal chemistry I
Practical MCQ Bank for experiments: Medicinal chemistry IPractical MCQ Bank for experiments: Medicinal chemistry I
Practical MCQ Bank for experiments: Medicinal chemistry ISONALI PAWAR
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug designProf. Aejaz Ahmed Boraji
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationSuvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdfSUJATA WANKHEDE
 

What's hot (20)

Pharmacognocy 5th sem with key
Pharmacognocy 5th sem with keyPharmacognocy 5th sem with key
Pharmacognocy 5th sem with key
 
Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic Compound
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Herbal excipients
Herbal excipientsHerbal excipients
Herbal excipients
 
Anti-tubercular agents
Anti-tubercular agentsAnti-tubercular agents
Anti-tubercular agents
 
Medicinal chemistry of Anti viral agents
 Medicinal chemistry of Anti viral agents  Medicinal chemistry of Anti viral agents
Medicinal chemistry of Anti viral agents
 
Assay demonstrations chloroquine
Assay demonstrations chloroquineAssay demonstrations chloroquine
Assay demonstrations chloroquine
 
Code of Pharmaceutical Ethics
Code of Pharmaceutical EthicsCode of Pharmaceutical Ethics
Code of Pharmaceutical Ethics
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agents
 
Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4
 
Medicinal chemistry of local anaesthetics
Medicinal chemistry of local anaestheticsMedicinal chemistry of local anaesthetics
Medicinal chemistry of local anaesthetics
 
Practical MCQ Bank for experiments: Medicinal chemistry I
Practical MCQ Bank for experiments: Medicinal chemistry IPractical MCQ Bank for experiments: Medicinal chemistry I
Practical MCQ Bank for experiments: Medicinal chemistry I
 
Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955
 
Herbal Drug Technology Unit 2 Neutraceuticals
Herbal Drug Technology Unit 2 NeutraceuticalsHerbal Drug Technology Unit 2 Neutraceuticals
Herbal Drug Technology Unit 2 Neutraceuticals
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
Industrial production, estimation and Utilization of Phytoconstituents
Industrial production, estimation and Utilization of PhytoconstituentsIndustrial production, estimation and Utilization of Phytoconstituents
Industrial production, estimation and Utilization of Phytoconstituents
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf
1. E-QUESTION BANK ON INTERNET 6TH SEM MC-III.pdf
 

Similar to Gpat mcqs-series part 2 ANS

Gpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsGpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsJafarali Masi
 
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs Karun Kumar
 
340 mcq drill with answers
340 mcq drill with answers340 mcq drill with answers
340 mcq drill with answersJake Duval-Smith
 
Gpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineGpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineJafarali Masi
 
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 ExaminationIVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 ExaminationImhotep Virtual Medical School
 
Mcqs in endocrine physiology for scientific review
Mcqs in endocrine physiology for scientific reviewMcqs in endocrine physiology for scientific review
Mcqs in endocrine physiology for scientific reviewms79vrq6zn
 
Sympathomimetics (ANS).pdf
Sympathomimetics (ANS).pdfSympathomimetics (ANS).pdf
Sympathomimetics (ANS).pdfemanabdelhamidxy
 
adrenergic drugs
adrenergic drugsadrenergic drugs
adrenergic drugsNasir Koko
 
Drug Acting on Autonomic Nervous System, Sympathetic nervous system, Sympa...
Drug Acting on Autonomic Nervous System,   Sympathetic nervous system,  Sympa...Drug Acting on Autonomic Nervous System,   Sympathetic nervous system,  Sympa...
Drug Acting on Autonomic Nervous System, Sympathetic nervous system, Sympa...Gulam Muheyuddeen
 
2. E-QUESTION BANK ON COGNOSY.pdf
2. E-QUESTION BANK ON COGNOSY.pdf2. E-QUESTION BANK ON COGNOSY.pdf
2. E-QUESTION BANK ON COGNOSY.pdfSUJATA WANKHEDE
 
Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Karun Kumar
 
اسئلة الطلاب
اسئلة الطلاباسئلة الطلاب
اسئلة الطلابPharma2014
 
Top 100 pharmacology mcq & ans
Top 100  pharmacology mcq & ansTop 100  pharmacology mcq & ans
Top 100 pharmacology mcq & ansPradeep Banjare
 
Pet and pet ct study guide
Pet and pet ct study guidePet and pet ct study guide
Pet and pet ct study guideSpringer
 

Similar to Gpat mcqs-series part 2 ANS (20)

Gpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cnsGpat mcqs-series part 4 cns
Gpat mcqs-series part 4 cns
 
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs
 
340 mcq drill with answers
340 mcq drill with answers340 mcq drill with answers
340 mcq drill with answers
 
Gpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrineGpat mcqs-series part 3 endocrine
Gpat mcqs-series part 3 endocrine
 
Tests
TestsTests
Tests
 
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 ExaminationIVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination
 
Mcqs in endocrine physiology for scientific review
Mcqs in endocrine physiology for scientific reviewMcqs in endocrine physiology for scientific review
Mcqs in endocrine physiology for scientific review
 
Sympathomimetics (ANS).pdf
Sympathomimetics (ANS).pdfSympathomimetics (ANS).pdf
Sympathomimetics (ANS).pdf
 
adrenergic drugs
adrenergic drugsadrenergic drugs
adrenergic drugs
 
Drug Acting on Autonomic Nervous System, Sympathetic nervous system, Sympa...
Drug Acting on Autonomic Nervous System,   Sympathetic nervous system,  Sympa...Drug Acting on Autonomic Nervous System,   Sympathetic nervous system,  Sympa...
Drug Acting on Autonomic Nervous System, Sympathetic nervous system, Sympa...
 
2. E-QUESTION BANK ON COGNOSY.pdf
2. E-QUESTION BANK ON COGNOSY.pdf2. E-QUESTION BANK ON COGNOSY.pdf
2. E-QUESTION BANK ON COGNOSY.pdf
 
Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Effect of drugs on frog’s heart
Effect of drugs on frog’s heart
 
Migrane
MigraneMigrane
Migrane
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
CVS simulation problem 2
CVS simulation problem 2CVS simulation problem 2
CVS simulation problem 2
 
اسئلة الطلاب
اسئلة الطلاباسئلة الطلاب
اسئلة الطلاب
 
امسكيو اسنان .pdf
امسكيو اسنان .pdfامسكيو اسنان .pdf
امسكيو اسنان .pdf
 
Top 100 pharmacology mcq & ans
Top 100  pharmacology mcq & ansTop 100  pharmacology mcq & ans
Top 100 pharmacology mcq & ans
 
Pet and pet ct study guide
Pet and pet ct study guidePet and pet ct study guide
Pet and pet ct study guide
 
autonomic system
autonomic system autonomic system
autonomic system
 

More from Jafarali Masi

Total quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMATotal quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMAJafarali Masi
 
Ocular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAOcular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAJafarali Masi
 
Intrauterine drug delivery system - ndds
Intrauterine  drug delivery system - nddsIntrauterine  drug delivery system - ndds
Intrauterine drug delivery system - nddsJafarali Masi
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Jafarali Masi
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIJafarali Masi
 
Pharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAPharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAJafarali Masi
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llJafarali Masi
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIJafarali Masi
 
Technology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llTechnology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llJafarali Masi
 
Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Jafarali Masi
 

More from Jafarali Masi (10)

Total quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMATotal quality management - QA - B.PHARMA
Total quality management - QA - B.PHARMA
 
Ocular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMAOcular drug delivery system - NDDS - B.PHARMA
Ocular drug delivery system - NDDS - B.PHARMA
 
Intrauterine drug delivery system - ndds
Intrauterine  drug delivery system - nddsIntrauterine  drug delivery system - ndds
Intrauterine drug delivery system - ndds
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
 
Pharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMAPharmaceutical warehousing - quality assurance -B.PHARMA
Pharmaceutical warehousing - quality assurance -B.PHARMA
 
Quality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY llQuality management systems - INDUSTRIAL PHARMACY ll
Quality management systems - INDUSTRIAL PHARMACY ll
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
 
Technology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy llTechnology development and transfer industrial pharmacy ll
Technology development and transfer industrial pharmacy ll
 
Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II Pilot plant scale up techniques - industrial pharmacy II
Pilot plant scale up techniques - industrial pharmacy II
 

Recently uploaded

Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 

Recently uploaded (20)

Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 

Gpat mcqs-series part 2 ANS

  • 1. GPAT-MCQS-SERIES PART-2 AUTONOMIC NERVOUS SYSTEM Jsmasipharmacy.blogspot.com SYLLABUS: Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics, Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic agents. Drugs used in Myasthenia Gravis. 1. Cholinergic M2 - and M3- receptors produce following effects: [P] Decreased heart rate [Q] Dilatation effect on salivary gland [R] Increased heart rate [S] Effect on erectile tissue (a) P and Q (b) Q and R (c) Q and S (d) P and S 2. Following statements are true: [P] Substance P is located at sympathetic ganglia [Q] Neuropeptide Y is located at postganglionic sympathetic neurons [R] Nitric oxide located at enteric neurons [S] Gonadotrophin-releasing hormone is not located at sympathetic ganglia (a) P and Q (b) P and R (c) Q and R (d) R and S 3. Following statements are true: [P] GABA transmitter is responsible for peristaltic reflex [Q] Neuropeptide Y facilitates constrictor action of adrenaline and inhibits adrenaline release
  • 2. [R] Substance P is co-transmitter with acetylcholine [S] Dopamine transmitter is responsible for vasoconstrictor (a) P and Q (b) Q and R (c) P and R (d) R and S 4. Following are the agonist of nicotinic receptor (α3)2: [P] Carbachol [Q] Trimetaphan [R] Hexamethonium [S] Acetylcholine (a) P and S (b) Q and R (c) P and R (d) R and S 5. Following are the agonist of muscarinic receptor M2: [P] Dicycloverine [Q] Ipratropium [R] Carbachol [S] Talsaclidine (a) Q and S (b) Q and R (c) P and Q (d) R and S 6. Following are the antagonist of nicotinic receptor (α1)2: [P] Cytosine [Q] Epibatidine [R] Atracurium [S] Vecuronium (a) Q and S (b) Q and R (c) P and Q (d) R and S 7. Following are the antagonist of muscarinic receptor: [P] Oxotremorine [Q] Oxybutynin [R] Tolterodine [S] Carbachol (a) Q and S (b) Q and R (c) P and Q (d) R and S 8. M2 receptor is responsible for following effects: [P] Cardiac inhibition [Q] Neural inhibition [R] Gastric secretion [S] Vasodilatation
  • 3. (a) P and Q (b) P and R (c) Q and S (d) Q and R 9. Following drugs lower the interocular pressure [P] Pilocarpine [Q] Lananoprost [R] Atropine [S] Tiotropium (a) P and Q (b) P and R (c) Q and S (d) Q and R 10. In urinary incontinence following drug is widely used: (a) Pirenzepine (b) Cyclopentolate (c) Darifenacin (d) Hyoscine 11. The main side effect of tubocurarine is [P] Bradycardia [Q] Bronchoconstriction [R] Hypotension [S] Cardiac arrhythmia (a) R and S (b) P and R (c) Q and S (d) Q and R 12. Following statements are true: [P] Hemicholinium inhibits the acetylcholine synthesis [Q] Parathion is a short duration anticholineterase [R] Botulinum toxin inhibits acetylcholine release [S] Physostigmine is used in treatment of myasthenia gravis (a) Q and R (b) P and R (c) R and S (d) P and Q 13. In the treatment of myasthenia gravis, the best agent for distinguishing between myashenic crisis and cholinergic crisis, given intravenously, is (a) Pyridostigmine (b) Edrophonium (c) Physostigmine (d) Neostigmine 14. Which of the following drug may cause cycloplegia when used topically in the eye?
  • 4. (a) Bethanechol (b) Physostigmine (c) Atropine (d) Pilocarpine 15. Epinephrine is added to local anaesthetics (a) To cause haemeostasis (b) To prolong the action of local anaesthetics (c) To stimulate wound healing (d) All of the above 16. Neostigmine may cause all of the followings except (a) Block accommodation reflex (b) Reversible inhibition of acetyl cholinesterase (c) Constipation (d) Bronchoconstriction 17. Following statements are true for β2 receptor [P] It produces glycogenolysis effect [Q] It produces lipolysis effect [R] It relaxes uterus [S] It produces constriction effect on bronchi (a) Q and S (b) Q and R (c) P and R (d) P and Q 18. Following statements are true for ritodrine [P] It is β2 agonist [Q] It produces arrhythmia as side effect [R] It is β1 agonist [S] It is used for nasal decongestion (a) P and Q (b) Q and R (c) P and R (d) Q and S
  • 5. 19. Following statement is true for labetalol [P] It is α and β antagonist [Q] It produces tachycardia as side effect [R] It is non-selective β antagonist [S] It is used in hypertension in pregnancy (a) Q and R (b) P and Q (c) P and S (d) R and S 20. Atropine over dosage may causes all of the following except (a) Miosis (b) Increased heart rate (c) Relaxation of GIT smooth muscle (d) Mental aberration 21. Orally effective sympathomimetics agent is [P] Epinephrine [Q] Isoproterenol [R] Ephedrine [S] Amphetamine (a) P and Q (b) Q and R (c) Q and S (d) R and S 22. Pilocarpineis classified as (a) Cholinesterase inhibitor (b) Sympathomimetic (c) Cholinomimetic (d) Cholinolytics 23. Propranolol is contraindicated in patients with (a) Angina pectoris
  • 6. (b) Supraventricular arrhythmias (c) Glaucoma (d) Hypertension 24. Mechanism of action of organic phosphate parathion is (a) Phosphorylation of the cationic site of cholinesterases (b) Phosphorylation of the esteratic site of cholinesterases (c) Acetylation of the esteratic site of cholinesterases (d) Acetylation of the cationic site of cholinesterases 25. Muscarinic receptor M3 are mainly located at [P] Exocrine gland [Q] Cerebral cortex [R] Heart [S] CNS (a) P and S (b) Q and R (c) P and R (d) R and S 26. Neostigmine effectively antagonizes skeletal muscle relaxation produced by (a) Tubocurarine (b) Gallamine (c) Pancuronium (d) All of the above 27. All of the following statements related to neostigmine are correct except (a) Neostigmine is a quaternary ammonium compound (b) Neostigmine is medium duration of action (c) Neostigmine has direct effect on neuromuscular junctions (d) All of the above 28. Muscarinic receptor M4 are mainly located at (a) Exocrine gland (b) Cerebral cortex (c) Heart (d) CNS
  • 7. 29. Antidote of atropine is (a) Neostigmine (b) Pralidoxime (c) Physostigmine (d) None of above 30. Atropine blocks the muscarinic actions of acetylcholine by (a) Inhibiting synthesis of ACH (b) Inhibiting release from storage sites (c) Competing at receptor sites (d) All of the above 31. Sweating is inhibited by (a) Atropine (b) Phenothiazines (c) Scopolamines (d) All of the above 32. Beta agonist used in bronchial asthma exert action by (a) Blocking B1 receptor (b) Blocking B2 receptor (c) Stimulating B1 receptor (d) Stimulating B2 receptor 33. Which of the following agent irreversibly bound with acetyl cholinesterase (a) Dispropyl flurophosphate (b) Ecothiopate (c) Both a and b (d) None of the above 34. Alcuronium is a semisynthetic derivative with similar properties of (a) Gallamine (b) Pancuronium (c) Succinylcholine (d) D-tubocurarine
  • 8. 35. Which of the following a is directly acting sympathomimetic agent? (a) Ephedrine (b) Amphetamine (c) Dopamine (d) All of the above 36. Antidote of organo phosphorous poisoning is (a) Physostigmine (b) Pralidoxime (c) Neostigmine (d) Tubocurarine 37. Action of D-tubocurarine is (a) Competitive blockade of musscarinic receptors (b) Competitive blockade of nicotinic receptors (c) Irreversible blockade of muscarinic receptor (d) None of above 38. Gingival hyperplasia is an oral condition possible in using (a) Phenobarbital (b) Phenytoin (c) Pentobarbital (d) Valproic acid 39. Which of the following agent is a cholinesterase re-activator? (a) Pilocarpine (b) Pralidoxime (c) Neostigmine (d) Physostigmine 40. Which of the following drug inhibits the acetylcholine synthesis? (a) Neomycin (b) Vasamicol (c) Botulinum toxin (d) Atropine 41. Tachyphylaxis is an unwanted effect of (a) Methohexamine (b) Methylphenidate (c) Ephedrine (d) Methamphetamine 42. Activation of alpha-2 receptors in the pancreatic islets causes (a) Suppression of insulin secretion (b) Stimulation of insulin release
  • 9. (c) Suppression of glucagon secretion (d) None of above 43. Darifenacin is a (a) M1 antagonist (b) M2 antagonist(c) M3 agonist (d) M3 antagonist 44. Which of the following drugs. do(es) not cross the blood–brain barrier? (a) Physostigmine (b) Neostigmine (c) Atropine (d) All of the above 45. Drug of choice in the treatment of cardiogenic shock is/are (a) Isoproterenol (b) Epinephrine (c) Dopamine (d) All of the above 46. Which of the following muscle relaxant has peripheral action? (a) Diazepam (b) Mephenesin (c) D-Tubocurarine (d) Orphenadrine 47. Pilocarpine is best used in (a) Congential glaucoma (b) Open angle glaucoma (c) Secondary glaucoma (d) All of the above 48. Timolol reduces the intraocular pressure by which mechanism of action? (a) Muscarinic agonist (b) Anticholinestarase (c) Carbonic anhydrase inhibitor (d) Beta-adrenoceptor antagonist
  • 10. 49. For glycogenolysis in liver one of the following adrenoreceptor is responsible: (a) Alpha-1 receptor (b) Alpha-2 receptor (c) Beta-1 receptor (d) Beta-2 receptor 50. Cardiac effects of epinephrine includes all except (a) Act on B – receptor of myocardium (b) Induced cardiac arrhythmias are blocked by propranolol (c) Prolong refractory period of AV nodes (d) Decrease the Amplitude of the T-waves of ECG 51. Serious unwanted effect of epinephrine is (a) Respiratory difficulty (b) Palpitation (c) Cerebral heamorrhage (d) Tremor 52. Drug of choice in motion sickness is (a) Atropine (b) Scopolamine (c) Carbamazepine (d) Metoclopromide 53. In belladonna poisoning convulsions can be controlled by (a) Paraldehyde (b) Phenytoin (c) Diazepam (d) Carbamazepine 54. Atropine are is used prior the administration of a general Aanaesthetics agent due tobecause it (a) Inhibits salivation and secretions of respiratory tract (b) Inhibits GIT motility (c) Prevents miosis (d) Causes skeletal muscle relaxation
  • 11. 55. Major adverse effect of clonidine is (a) Bradycardia (b) Tachycardia (c) Sexual dysfunction (d) Dry mouth 56. Ganglionic blocking agents may cause all of the following except (a) Mydriasis (b) Loss of accommodation (c) Reduced sweating is reduce (d) Inhibit erection and ejaculation Answer Keys 1. (a) 2. (a) 3. (c) 4. (c) 5. (d) 6. (d) 7. (a) 8. (a) 9. (a) 10. (c) 11. (d) 12. (b) 13. (b) 14. (c) 15. (b) 16. (c) 17. (c) 18. (a) 19. (c) 20. (a) 21. (d) 22. (c) 23. (c) 24. (b) 25. (a) 26. (d) 27. (d) 28. (d) 29. (c) 30. (d) 31. (d) 32. (d) 33. (c) 34. (d) 35. (c) 36. (b) 37. (b) 38. (b) 39. (b) 40. (b) 41. (c) 42. (a) 43. (d) 44. (b) 45. (c) 46. (c) 47. (b) 48. (d) 49. (a) 50. (c) 51. (c) 52. (b) 53. (c) 54. (a) 55. (d) 56. (d)